© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Chemistry often writes its history through the tools it invents. 1,1'-Carbonyldiimidazole (CDI) entered the chemist’s toolkit in the mid-20th century as an alternative to harsher activating agents found in peptide synthesis and other organic reactions. Back in those early days, peptide coupling frequently involved reagents that prompted severe side reactions, difficult workups, or both. CDI quickly promised more efficient processes, sidestepping some of the challenges presented by older methods. Over the last few decades, with the need for cleaner and more reproducible chemical transformations growing, folks kept coming back to CDI as a trusted activator and coupling agent.
Anyone who's spent enough time at a lab bench learns that CDI appears in many experimental setups. This white, crystalline compound has played a quiet but steady role in daily research, far beyond the notoriety of flashy catalysts or elaborate ligands. As a coupling and condensing agent, it enables the formation of amide bonds and facilitates esterification in both academic studies and industrial manufacturing. Watching it ease the process of activating carboxylic acids—eliminating the need for acid chlorides—frees researchers from exposure to corrosive reagents. The result: less fuss and more focus on what truly matters—the chemistry at hand.
CDI brings both stability and predictable behavior to the table. Under standard conditions, it keeps its white, almost powdery form, melting at a temperature that sets it apart from more volatile or reactive options. It dissolves in polar aprotic solvents, such as dimethylformamide or dichloromethane, giving flexibility to those setting up reactions. It handles storage and transport far better than many equivalents, resisting decomposition under moderate conditions. This sturdiness in storage means bottles of it on the shelf last, providing reliable results each time they're used.
Navigating shelves of chemicals, I always look for rigor in labeling and handling. With CDI, attention goes not only to the purity—commonly above 98 percent in most research settings—but also to moisture content and packaging. Precise technical data support safe, successful applications: knowledge of melting point, solubility, and sensitivity helps avoid ruined reagents or failed syntheses. Those labels, though, shouldn’t lull anyone into complacency. The catalog data opens a door, yet the real understanding comes with careful handling and repeated experience at the bench.
The synthesis of CDI itself usually starts from basic imidazole and phosgene or safer phosgene equivalents. This approach reflects a tension often felt in organic synthesis: the drive to find routes that give high yields while avoiding dangerous or hard-to-handle reagents. While phosgene draws concern from many—given its toxic, choking nature—ongoing improvements in containment and phosgene replacement chemistry have made CDI far more accessible. Scaling up, as industrial chemists have learned, poses its own hazards, requiring failsafe measures and rigorous operator training. My own experience in the lab underscores a simple lesson: even when synthetic routes get easier, respect for the dangerous steps must never fade.
Most organic chemists can recall their first CDI-mediated coupling, where the transformation seemed almost effortless. This reagent excels at activating carboxylic acids for amide and ester formation by producing a reactive intermediate without pesky byproducts like HCl. Those using CDI for peptide synthesis, alkylation, or phosphorylation enjoy clean, high-yielding transformations. In modification chemistry, CDI’s imidazole groups interact as efficient leaving groups, allowing new bonds to forge in milder, more controlled environments. Time and again, as research shifts toward increasingly complex molecules, the ease of further tweaking the CDI backbone with various substituents allows creative adaptations and integration into broader reaction schemes.
Strolling through journal articles or supplier lists, I’ve run into CDI under a variety of names: Carbonyl diimidazole, carbonyldiimidazole, 1,1'-CDI, or even just ‘CDI’ in shorthand among colleagues. This linguistic scatter reflects the chemical’s widespread adoption across disciplines, yet it also calls for vigilance. A missed synonym can send researchers down the wrong path or leave important data undiscovered during literature reviews. Effective communication in chemistry circles hinges on clarity, and knowing the various names for critical reagents helps everyone find the right answers—and avoid costly mistakes.
CDI seems benign compared to some noxious chemicals found in synthetic labs, but safety basics never go out of style. This compound produces imidazole—a mild base—upon hydrolysis, but its capacity to react with moisture means gloves and eye protection aren’t optional. While accidental skin or eye contact usually only causes irritation, repeated exposure brings cumulative health risk through sensitization. Good ventilation and careful containment prevent airborne dust from becoming an issue. Anyone storing or disposing of CDI must keep it dry and shielded from acids or strong bases, reducing incident rates and protecting the next researcher in line. In industrial practice, larger volumes and heightened concentrations turn minor inconveniences into safety priorities, emphasizing standardized operational protocols supported by consistent training.
Peptide synthesis, DNA modification, and pharmaceutical manufacturing all rely heavily on CDI. I’ve watched academic teams turn to it during the rapid prototyping of peptide analogs for cancer therapy research, finding it reliable enough for sensitive and expensive building blocks. Outside of life sciences, CDI helps form polymers or surface coatings where selective activation of functional groups is a must. In bioconjugation, its role extends further, bridging proteins with fluorescent tags or therapeutic leads with remarkable efficiency. Researchers in both established and startup settings value the flexibility—CDI’s reach crosses chemical, biological, and material boundaries with ease.
Innovation in CDI use hasn’t slowed, even after decades of reliance. Teams continue probing how to make activation and coupling reactions even milder, more selective, or less wasteful. By exploring derivatives and alternative reagents, researchers aim to reduce hazardous byproducts and streamline purification. Recent advances showcase CDI derivatives unlocking new crosslinking routines for next-generation polymers and drug conjugates. This push for improvement reflects a wider industry trend: the relentless drive to minimize environmental impact, lower costs, and broaden the range of compatible functional groups in organic synthesis.
Toxicological profiles of CDI have gained more attention as its use expands. Acute exposure at laboratory concentrations typically leads to local irritation—skin, eyes, or respiratory tract. Chronic studies, meanwhile, warn of allergy risk with repeated contact, while oral or high-level exposures can bring on systemic effects that demand prompt treatment. Environmental impact also looms large; CDI breaks down in the presence of water but forms imidazole, which must be assessed for local ecosystem compatibility during disposal. Research teams balancing productivity with worker health and environmental safety have pushed for even stricter exposure limits, tighter containment, and clear labeling—one of many reasons I always double-check safety protocols before starting a synthesis involving CDI.
CDI’s best days may still lie ahead if emerging trends in green chemistry and advanced bioconjugation take hold. Researchers seek not just safer peptide synthesis, but smarter, more adaptable coupling agents for complex molecules—think targeted cancer drugs or responsive biomaterials. Development of CDI analogs promises novel routes and reaction choices, while sustained innovation in reactor design opens doors to continuous manufacturing and in-line purification. Academic and industrial chemists join forces more often now, sharpening CDI’s benefits through collaboration and shared best practices. With new fields surfacing all the time, CDI sits ready to push into fresh territory—particularly in bio-orthogonal labeling, therapeutic development, and environmentally benign synthesis. It’s clear: a reagent’s legacy grows by adapting to the times, and CDI is more than keeping pace.
1,1'-Carbonyldiimidazole, or CDI for those who work with it, pops up in almost every chemistry lab with any focus on organic synthesis. Its role? Making the tough job of building molecules a little smoother, especially where forming bonds matters most. The first time I slid a vial of CDI across the bench, I watched experienced chemists talk up its value for connecting pieces that just wouldn't stick on their own. That stuck with me, even after the reaction was cleaned up and the caffeine wore off.
People often turn to CDI during the early stages of making pharmaceuticals. Pharmaceutical chemists need to connect molecules efficiently and safely, especially when scaling up for industrial production. CDI helps link up amines and carboxylic acids—two building blocks found in medicines, agrochemicals, and even some modern materials. Lab teams use CDI to form “amide bonds,” which crop up in everything from antibiotics to peptides. Crossing the hurdle of stubborn chemical bonds saves time and cuts waste.
CDI's performance comes from its ability to transform carboxylic acids into intermediates called “activated esters,” which hand off parts of molecules where needed. For research teams making candidate drugs or chasing new antibiotics, these shortcuts are invaluable. In my own work, we've weighed different reagents, and CDI heads the list for stability, low toxicity, and its knack for handling moisture better than rivals like carbodiimides.
The reach of CDI extends to making new materials. Polymers—the backbone of plastics and coatings—depend on the same bond-forming steps that CDI enables. Labs pushing the limits of electronics, packaging, and biocompatible implants have used CDI to assemble large molecular structures. From my own projects on flexible circuits, I’ve seen CDI allow connections that more finicky agents would spoil. Sometimes, this is the difference between a project that sits in a notebook and one that moves toward production.
Safety hovers near the top of any chemical user’s list. CDI offers relatively mild handling hazards compared to older coupling agents like phosgene or dicyclohexylcarbodiimide. I remember the relief among colleagues when switching to CDI meant fewer headaches and less trouble with corrosive byproducts. Still, CDI produces imidazole as a byproduct and prompts a fresh look at solvent choices and waste. Chemists now explore solvent recycling and greener processes to keep pace with sustainability goals. Pharmaceutical companies track waste streams, and universities teach new chemists to think about the life cycle of every reagent.
Demand for new medicines and advanced materials keeps CDI firmly in the spotlight. Its effectiveness and versatility play a big part in shaping chemical research and manufacturing. Still, smarter choices in waste management and solvent systems can raise the bar. Some labs use solid-supported versions of CDI to simplify cleanup and cut down on unwanted residue. Remote sensors and better airflow also keep workspaces healthier. I’ve watched lab managers insist on updated protocols, making CDI a tool that fits into safer, cleaner, and more responsible research settings.
CDI isn’t a household name, but its influence flows through products people trust every day. Whether shaping a new drug, driving a cleaner manufacturing process, or giving research teams an edge, CDI represents that blend of practicality and innovation that keeps labs moving forward. It’s rewarding to see a reagent bring us closer to breakthroughs while nudging chemical practice toward greater responsibility.
Chemicals like 1,1'-Carbonyldiimidazole—or CDI, as chemists call it—deserve respect in the lab, garage, or factory shelf. CDI’s reactive nature makes storage a real safety topic. I’ve seen more than a few mishaps that started with shortcuts and ended with lost work, property damage, and in one case, a scary trip to the ER. Nobody wants that. That’s why I always take chemical storage seriously, from the first shipment to the very last gram.
CDI reacts with water like a spark to dry leaves. Just a little moisture in the bottle will spoil it—wrecking purity and creating hazardous byproducts like imidazole and carbon dioxide. In my own experience, even a poorly sealed cap after routine use can turn valuable reagent into trash. If you want reliability in synthesis and to pass a lab audit with flying colors, airtight containers are a non-negotiable step. Glass bottles with PTFE-lined caps get my vote every time. Less fuss, more peace of mind.
CDI doesn’t take kindly to high temps. Its shelf life falls off a cliff if stored in a warm spot, leading to degradation and, again, lost money and results. I always keep my CDI stocks in a cool, well-ventilated chemical cabinet—far from sunlight, far from hot pipes, far from heating vents. Room temperature might sound safe, but swings from sunlight or faulty air conditioning can sneak up if you aren’t vigilant. Fridges for chemicals help, but only if moisture can’t sneak in. Chemistry wins or fails with this kind of attention to detail.
I once saw someone put CDI right next to acids and moist reagents. That’s asking for trouble. The storage spot tells half the safety story: neighboring chemicals matter. Store it beside solvents, desiccants, or other water-sensitive compounds, but keep it clear of sources of moisture, acids, and bases. Getting this detail wrong leads to ruined product and possible exposure, including toxic gas releases. CDI’s not wild about company, so keep its shelf space exclusive.
Clear labeling solves half the problems before they start. You don’t want anyone reaching for CDI thinking it’s washing powder. Proper hazard symbols, date of opening, and dedicated chemical logs do help. Nothing’s more frustrating than losing track of who last used the bottle or whether air already crept inside. Trust me—one missing log entry can turn inventory tracking into a week of confusion.
Some labs go the extra mile, using gloveboxes for air-sensitive procedures. If you can swing it, do so. Otherwise, at home or in smaller labs, transfer chemicals only in dry boxes or with a good dry-gas purge. Never skip goggles and gloves with CDI. Chemical burns and allergies from carelessness outlast any shortcut’s convenience.
Safe, smart storage habits protect health, research, jobs, and budgets alike. Stories float around of accidents and lost reagents, but most are preventable through constant diligence and good sense. CDI can do a lot of good if you treat it the right way. I’ve found that storing CDI like it matters tends to prove that it does.
1,1'-Carbonyldiimidazole, or CDI for short, turns up a lot in chemistry labs, especially where peptide synthesis and other specialized reactions happen. Speaking from years of working benches and cleaning glassware, chemicals like this demand respect and a bit of extra attention. Safety slips are easy to make, and CDI’s hazards feel easy to underestimate. CDI makes life easier for chemists, but that doesn’t mean it’s friendly if handled carelessly.
CDI can irritate the skin, damage eyes, and even cause respiratory issues. A splash in the eye or a cloud in the nose brings trouble fast. This stuff reacts with water, breaking down to imidazole, which is also irritating. Accidental exposure may not seem urgent right away, but too many talented students have lost time to eye injuries or asthma attacks. Experts from the National Institutes of Health and American Chemical Society have flagged CDI for allergic reactions—and long-term exposure isn’t well-studied. CDC records show growing concern for respiratory sensitization in lab workers who use CDI frequently. Given all that, skipping PPE one day really isn’t worth the risk.
Personal protective equipment sets the baseline: lab coat, safety glasses, and gloves should go on before you even touch a CDI container. Some labs keep a fume hood running so any CDI powder stays out of noses and lungs. I remember old timers shouting reminders—never pipette with mouth, never weigh CDI outside a hood, keep a spill kit close. Gloves made from nitrile or another strong material give a good barrier, but remember, CDI can sneak through if you wear the same pair too long or touch contaminated surfaces. That’s why people change gloves after every weighing or spill.
CDI loves to react with water, so moisture control gets serious attention. Keep bottles sealed until use, try to store the chemical in a dry desiccator, and wipe down any work bench right after use. I’ve seen what happens after a messy spill—a cloud of imidazole in the air and colleagues coughing for hours, even after the floor crew mopped up. It’s fine to double up on precautions if you’re in doubt: more absorbent pads, extra containers, and dedicated tools help keep things clean. Proper labeling on all bottles and waste reduces confusion, even during busy stretches.
All CDI waste, including contaminated gloves, paper, and leftover solution, goes in a designated waste container. Dumping anything with CDI down the drain invites trouble. Most labs work with hazardous waste contractors who know the right way to neutralize and dispose of it. If leftover CDI sits out, it can slowly decompose, leaving a crusty mess that’s tougher to clean and could irritate skin or eyes hours later. My favorite trick is to set aside a separate trash bag for CDI work, seal it up immediately, and sign your name so nobody else handles it by mistake. Making it routine goes a long way to shaping good lab habits.
Most lab accidents have one root cause: rushing or skipping steps because “it’s a small amount.” CDI doesn’t care how confident you feel. Stay consistent about PPE, clean up after every use, and check for fresh air in your space. Each good habit pays off in fewer close calls, and everyone goes home in one piece. If you’re ever unsure, ask a senior colleague or reread your institution’s chemical safety sheet—no experiment runs faster than injury slows you down.
Anyone working in a chemistry lab catches sight of plenty of reagent bottles marked “CDI.” That’s the shorthand for 1,1'-Carbonyldiimidazole, a compound chemists reach for every week. Weighing the right amount can decide if an experiment works or sends you back to the bench to start again. So the molecular weight isn’t trivia — it’s a workhorse number. Checking the periodic table: each imidazole ring brings in five carbons, four nitrogens, four hydrogens; a carbonyl group adds a carbon and an oxygen. All together, that's C7H6N4O, ringing in at 162.15 g/mol.
No one forgets their first failed coupling reaction. Mine involved poorly measured CDI because someone misread the label. Too little, and you never see product form; too much, and quenching the reaction gets messy, not to mention it hits your lab budget. For anyone looking to synthesize peptides or modify carboxylic acids, precision matters. Using CDI in place of phosgene wasn’t just about safety — the accuracy of the calculation played a role in both clean-up and downstream yield. Even trusted journals, like Journal of Organic Chemistry, note the importance of keeping ratios tight, and that only happens with the correct molecular weight on hand.
Say you want to scale up your synthesis. That tiny difference — just a decimal point in a molecular weight — multiplies fast when calculating for multi-gram batches. In industry, that could mean saving or wasting hundreds of dollars in a week. Researchers racing to publish realize that suppliers occasionally change their packaging or purity, which makes double-checking the listed molecular weight a habit worth sticking to. I’ve heard stories where a colleague got stuck thanks to a mislabeled bottle; no one wants that kind of delay, especially in pressure-cooker environments where patents and grant money ride on hitting deadlines.
CDI steps in because of safety, avoiding the hazards linked to phosgene. We can’t ignore that compounds with similar names can have different weights. It sounds obvious, but swapping out an imidazole for a benzimidazole, for example, throws off the math. This isn't just hearsay: data from chemical suppliers shows a surprising number of order mix-ups trace back to this mix-up. Mistakes on the bench echo in published data. Peer reviewers spot errors in calculated yields and quickly flag journals, costing time and credibility. Consistency in documentation, and checking every value rather than trusting memory, stands out as one of the simplest real fixes for repeatable research.
The lesson from years working with CDI and other coupling agents? Discipline. Double-check the SDS, confirm each calculation, and create a habit of referencing a trusted database such as PubChem — which confirms 162.15 g/mol for 1,1'-Carbonyldiimidazole. Labs that set this expectation avoid a whole lot of headaches, because it’s the details that pile up to make good science — or break it. That’s why the right molecular weight isn’t just a number, it’s the foundation of trustworthy results and safe, sustainable chemistry.
Anyone who has spent time in a synthetic chemistry lab recognizes the value of 1,1'-Carbonyldiimidazole, or CDI. It activates acids and forms carbamates and ureas, paving the way for clean, mild reactions. The trick lies in getting it to go into solution cleanly and completely, preventing clumps and uneven mixing that cut into yields and trust in your work-up.
CDI's structure helps a lot—it isn't sticky like a lot of other coupling agents. It pours from the bottle as an off-white powder, not a dense resin. Still, one can’t sprinkle it into just any solvent. Work calls for thought about solubility, reactivity, and, sometimes, common sense based on the fumes and safety hazards each liquid brings.
Most chemists reach for common polar aprotic solvents. Acetonitrile does the job very smoothly, helping CDI dissolve quickly with a gentle swirl. Many have had good luck with tetrahydrofuran (THF) and dimethylformamide (DMF). Both let CDI go fully into solution—giving a clear, transparent liquid free of floating particles. The choice often follows what else is in the flask. DMF works for more polar starting materials. THF offers broader use across less-polar reactions.
Don't forget dry conditions. CDI reacts with water, sometimes fizzing or clumping if there's even a hint of humidity in the air. Even a few drops of water in your glassware eat into your final product. Dry solvents, freshly distilled if you're in a high-precision environment, save money down the line and keep the reaction honest. It pays to check the MSDS—CDI can irritate the skin, so avoid breathing dust or touching it directly.
Too often, a rushed set-up leads to strange opalescence or chunks that stick to the bottom of the flask. Sometimes the answer is to slow down and take stock. If you see undissolved powder, gentle warming (not boiling) or stirring usually clears things up. Stubborn clumps usually point back to moisture.
In a world where time and material matter, minimizing waste keeps costs and environmental impact low. Watching a batch go bad due to poor CDI mixing drains enthusiasm and trust in a method. Many teams use argon or nitrogen atmospheres to keep things dry—a habit as familiar as putting on a lab coat. Gloves and eye protection aren't just theater; CDI can sting. Inexperienced hands often tip too much directly into the solvent, trying to rush. A little patience pays off.
Where possible, scale down reactions to watch new conditions. A test tube run stings less than losing grams of expensive starting material. Data from journals back this up: most successful papers using CDI favor acetonitrile, DMF, or THF, with strict notes about anhydrous conditions. Stay organized. Lay out everything—dry syringes, oven-dried glassware, a working stir bar—before uncapping the CDI bottle.
Solving the dissolving puzzle for CDI gives sharper results and helps everyone in the lab avoid wasted time and risk. Paying attention to solvent, dryness, and safe handling takes only a few minutes, but the payoff comes in happier results and fewer repeats.
| Names | |
| Preferred IUPAC name | Imidazol-1-yl)carbonyl]imidazole |
| Other names |
CDI Carbonyldiimidazole N,N′-Carbonyldiimidazole 1,1′-Carbonyldiimidazole Imidazole-1-carboxylic acid, anhydride Imidazole carbonyl Carbonyl diimidazole |
| Pronunciation | /ˌkɑːrˌboʊ.naɪl.daɪ.ɪˈmɪ.dəˌzoʊl/ |
| Identifiers | |
| CAS Number | 530-62-1 |
| 3D model (JSmol) | `3D model (JSmol)` string for **1,1'-Carbonyldiimidazole**: ``` CC1=NC=CN1C(=O)N2C=NC=CN2 ``` |
| Beilstein Reference | 1737219 |
| ChEBI | CHEBI:39049 |
| ChEMBL | CHEMBL14887 |
| ChemSpider | 7371 |
| DrugBank | DB03627 |
| ECHA InfoCard | 100.084.894 |
| EC Number | 204-498-2 |
| Gmelin Reference | 82136 |
| KEGG | C05367 |
| MeSH | D003605 |
| PubChem CID | 3496 |
| RTECS number | LW3530000 |
| UNII | Q40Z2605C8 |
| UN number | 3261 |
| CompTox Dashboard (EPA) | DTXSID4020377 |
| Properties | |
| Chemical formula | C7H6N4O |
| Molar mass | 162.16 g/mol |
| Appearance | White to off-white crystalline powder |
| Odor | Odorless |
| Density | 1.42 g/cm³ |
| Solubility in water | Reacts slowly with water |
| log P | 0.4 |
| Vapor pressure | 0.01 hPa (25 °C) |
| Acidity (pKa) | 12.46 |
| Basicity (pKb) | 15.1 |
| Magnetic susceptibility (χ) | -44.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.568 |
| Viscosity | 2.15 mPa·s (25 °C) |
| Dipole moment | 3.48 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 247.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -178.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1453 kJ mol⁻¹ |
| Pharmacology | |
| ATC code | V03AB37 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes severe skin burns and eye damage, may cause respiratory irritation. |
| GHS labelling | GHS02, GHS07, GHS08 |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | H302 + H315 + H319 + H335 |
| Precautionary statements | P261, P280, P305+P351+P338, P337+P313, P302+P352 |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | 199°C |
| Autoignition temperature | 245 °C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 940 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral, rat = 940 mg/kg |
| NIOSH | MW4025000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.5 mg/m³ |
| Related compounds | |
| Related compounds |
Urea Imidazole Triphosgene Phosgene |
